Intensity Therapeutics, Inc.
Biotechnology company · Shelton, Connecticut, United States · Nasdaq: INTS
Intensity Therapeutics, Inc. is a biotechnology company headquartered in Shelton, Connecticut, United States. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker INTS. It has reported private securities offerings to the US SEC, most recently $3.6 million sold in a notice filed in 2024.
Intensity Therapeutics at a glance
What does Intensity Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $3.6 million sold (2024).
Frequently asked questions about Intensity Therapeutics
Where is Intensity Therapeutics headquartered?
Intensity Therapeutics, Inc. is headquartered in Shelton, Connecticut, United States.
What does Intensity Therapeutics do?
Intensity Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Intensity Therapeutics a public company?
Yes. Intensity Therapeutics, Inc. trades on Nasdaq under the ticker INTS.
When was Intensity Therapeutics founded?
The earliest incorporation on record for Intensity Therapeutics, Inc. is in 2012, according to public company registers.
Similar companies
- MycoMedica Life Sciences, PBCShelton, Washington, United States
- Gsno Therapeutics, Inc.Shelton, Washington, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences